The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Bausch & Lomb's share price is C$20.52.
Bausch & Lomb's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was C$15.94. Hence, Bausch & Lomb's PS Ratio for today is 1.29.
Good Sign:
Bausch & Lomb Corp stock PS Ratio (=1.28) is close to 2-year low of 1.18
The historical rank and industry rank for Bausch & Lomb's PS Ratio or its related term are showing as below:
TSX:BLCO'
s PS Ratio Range Over the Past 10 Years
Min: 1.18 Med: 1.52 Max: 1.85
Current: 1.27
During the past 6 years, Bausch & Lomb's highest PS Ratio was 1.85. The lowest was 1.18. And the median was 1.52.
TSX:BLCO's PS Ratio is ranked better than 78.09% of 808
companies
in the Medical Devices & Instruments industry
Industry Median: 3.175
vs TSX:BLCO: 1.27
Bausch & Lomb's Revenue per Sharefor the
three
months ended in Dec. 2023 was C$4.49.
Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was C$15.94.
During the past 12 months, the average Revenue per Share Growth Rate of Bausch & Lomb was 8.60% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 8.30% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 2.30% per year.
During the past 6 years, Bausch & Lomb's highest 3-Year average Revenue per Share Growth Rate was 8.30% per year. The lowest was -0.70% per year. And the median was 0.90% per year.
Back to Basics: PS Ratio
Bausch & Lomb PS Ratio Historical Data
The historical data trend for Bausch & Lomb's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Bausch & Lomb's PS Ratio
For the Medical Instruments & Supplies subindustry, Bausch & Lomb's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bausch & Lomb's PS Ratio Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bausch & Lomb's PS Ratio distribution charts can be found below:
* The bar in red indicates where Bausch & Lomb's PS Ratio falls into.
Bausch & Lomb PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Bausch & Lomb's PS Ratio for today is calculated as
Bausch & Lomb's Share Price of today is C$20.52.
Bausch & Lomb's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$15.94.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Bausch & Lomb PS Ratio Related Terms
Thank you for viewing the detailed overview of Bausch & Lomb's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Bausch & Lomb is one of the largest vision care companies in the U.S. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market which B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSX:BLCO has been successfully added to your 